Huntington National Bank’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57 Hold
2
﹤0.01% 3013
2026
Q1
$35 Hold
2
﹤0.01% 3143
2025
Q4
$38 Hold
2
﹤0.01% 3002
2025
Q3
$29 Hold
2
﹤0.01% 3216
2025
Q2
$39 Hold
2
﹤0.01% 3084
2025
Q1
$36 Hold
2
﹤0.01% 3152
2024
Q4
$43 Hold
2
﹤0.01% 3072
2024
Q3
$62 Hold
2
﹤0.01% 2876
2024
Q2
$31 Hold
2
﹤0.01% 3202
2024
Q1
$21 Sell
2
-76
-97% -$760 ﹤0.01% 3269
2023
Q4
$936 Buy
78
+76
+3,800% +$623 ﹤0.01% 2229
2023
Q3
$14 Hold
2
﹤0.01% 3304
2023
Q2
$17 Hold
2
﹤0.01% 3211
2023
Q1
$18 Hold
2
﹤0.01% 3029
2022
Q4
$23 Hold
2
﹤0.01% 2781
2022
Q3
$0 Hold
2
﹤0.01% 2039
2022
Q2
$0 Hold
2
﹤0.01% 2070
2022
Q1
$0 Hold
2
﹤0.01% 2066
2021
Q4
$0 Buy
2
+1
+100% +$52 ﹤0.01% 2041
2021
Q3
$0 Buy
+1
New +$76 ﹤0.01% 1808

Other funds holding CDNA

Huntington National Bank's CDNA Position: Q2 2026 in Review

Huntington National Bank held its CareDx (CDNA) position steady in Q2 2026 at 2 shares worth $57. The position accounts for ﹤0.01% of the portfolio, ranked #3013.

Huntington National Bank first reported a position in CDNA in Q3 2021 and has held it in 20 quarters since. The position peaked at $936 in Q4 2023. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Huntington National Bank held 2 shares of CareDx worth $57 as of Q2 2026.
  • Huntington National Bank left its CareDx share count unchanged in Q2 2026.
  • CareDx made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #3013 holding.
  • Huntington National Bank first reported a position in CareDx in Q3 2021 and has held it in 20 quarters since.
  • Huntington National Bank's CareDx position peaked at $936 in Q4 2023.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.